Work

OA 14.06 Entrectinib in Patients with Locally Advanced or Metastatic ROS1 Fusion-Positive Non-Small Cell Lung Cancer (NSCLC)

Year: 2017

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2017.09.411

Authors: M. Ahn, B.C. Cho, S. Siena, A. Drilon, F. De Braud, M. Krebs, T. John, C. Karapetis, A. Johnson, E. Chow-Maneval, P. Multani, R. Doebele

Institutions: Samsung Medical Center, Yonsei University, Yonsei University Health System, Yonsei Cancer Hospital, Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Memorial Sloan Kettering Cancer Center, Fondazione IRCCS Istituto Nazionale dei Tumori, University of Manchester, The Christie NHS Foundation Trust, Austin Hospital, Austin Health, Flinders Medical Centre, Ignyta (United States), University of Colorado Anschutz

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2767549343

FWCI: 3.179

Cites:

Cited by: 15

Related to: 10